Ke Xu

机构：Fujian Medical University, Fujian Entry - Exit Inspection and Quarantine Bureau · ORCID：0009-0006-0672-0254

发表论文 21 篇 · 总被引 323 次 · h-index 6

代表论文

• Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal glucose metabolism (2024 · Cardiovascular Diabetology · 被引 132)
• MAVS integrates glucose metabolism and RIG-I-like receptor signaling (2023 · Nature Communications · 被引 58)
• Comparing the effects and mechanisms of exposure to polystyrene nanoplastics with different functional groups on the male reproductive system (2024 · The Science of The Total Environment · 被引 42)
• THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy (2021 · Journal for ImmunoTherapy of Cancer · 被引 39)
• Robotic-assisted navigation system for preoperative lung nodule localization: a pilot study (2023 · Translational Lung Cancer Research · 被引 25)
• Exploring the molecular and immune-landscape of lung cancer associated with cystic airspaces (2024 · Molecular Immunology · 被引 9)